Analysis of the Essential Transcription Factors Spt5 and Spn1/Iws1
必需转录因子 Spt5 和 Spn1/Iws1 的分析
基本信息
- 批准号:9754185
- 负责人:
- 金额:$ 48.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntisense RNAAreaB-LymphocytesBindingBiological AssayBiological ModelsBypassCell SurvivalCellsChIP-seqChromatinChromatin StructureComplexDNADefectEAF1 geneElongation FactorEssential GenesFission YeastGap JunctionsGene ExpressionGenesGenetic TranscriptionGenetic studyGenomic approachGrowth and Development functionHIVHealthHistonesHumanHuman BiologyImmunoglobulin Class SwitchingImpairmentLearningMalignant NeoplasmsMapsMethodsMolecular ChaperonesMutationNamesNucleosomesOrganismPilot ProjectsPlayPositioning AttributeProcessProteinsRNARNA Polymerase IIRNA SplicingRegulationRepressionResolutionRoleSaccharomyces cerevisiaeSiteStructureStudy modelsSuppressor MutationsTestingTranscriptTranscription ElongationTranscription Initiation SiteTranscription ProcessTranscriptional Elongation FactorsYeastschimeric geneexperimental studygenetic approachgenetic informationgenome-widehistone methylationhistone modificationhuman diseaseimprovedin vivoinsightmRNA cappingmutantnovelpromoterprotein functiontranscription factortranscription factor S-IItranscriptome sequencing
项目摘要
PROJECT SUMMARY/ABSTRACT
The long-term objectives of this project are to increase our understanding of eukaryotic transcription
elongation. The focus of the proposed experiments is the analysis of two essential transcription elongation
factors named Spt5 and Spn1 (also known as Iws1). Both factors have been implicated in human health. Spt5
is required for HIV gene expression, expression of NF-B-activated genes, and it is required for
immunoglobulin class switching in B cells. Spn1 has been implicated in cancer. For both factors, there are
several important areas where little is understood. Preliminary studies of Spt5 in the model system, S. pombe,
have provided strong evidence that Spt5 is required for normal levels of transcription elongation genome-wide,
with Spt5 required for RNA polymerase II to elongate past a barrier. These studies have also shown that Spt5
represses a novel class of antisense transcript that initiates at or near the barrier and that is synthesized
across the 5' ends of the majority of genes. The proposed experiments in Specific Aim 1 address three
related areas, continuing to use S. pombe as a model system. In Aim 1.1, two genome-wide approaches
(MNase-seq and TSS-seq), will be employed to (1) test whether Spt5 controls chromatin structure and (2) to
map the 5' ends of the antisense RNAs as a way to localize the antisense promoters and barriers with respect
to nucleosome position. The results will provide new and comprehensive characterization of the role of Spt5 in
transcription and chromatin structure. Aim 1.2 will focus on the sequences that have three possible functions:
the barrier to elongation, the antisense promoter, and a possible site that stimulates elongation. Constructs will
be made and tested to define the sequences required for these functions. The results will provide new insights
into a previously unstudied aspect of eukaryotic transcription elongation. Aim 1.3 addresses the Spt5 protein
itself, focusing on the isolation of new spt5 mutations that impair elongation. The positions and defects in the
mutant proteins will reveal new understanding of Spt5 protein function. Specific Aim 2 proposes experiments
in S. cerevisiae to understand the transcription factor Spn1. Aim 2.1 proposes two methods, RNA-seq and
NET-seq, to characterize changes in transcription in Spn1-depleted cells, and ChIP-nexus, a high-resolution
ChIP-seq method, to characterize chromatin association of specific factors and histone modifications after
Spn1 depletion. Aim 2.2 proposes the isolation of mutations that bypass the need for Spn1, to understand the
requirements for Spn1 in vivo. Mutations isolated in a pilot study have identified factors required for
transcription elongation. These studies will provide new insights into the function of Spn1 within the
transcription elongation complex. Together, these studies will greatly advance understanding of Spt5 and Spn1
and thereby increase understanding of transcription and co-transcriptional processes. As Spt5 and Spn1 are
conserved, what is learned in studying these model systems will be directly relevant to human biology.
项目概要/摘要
该项目的长期目标是增加我们对真核转录的理解
所提出的实验的重点是分析两个基本的转录延伸。
Spt5 和 Spn1(也称为 Iws1)这两个因子都与人类健康有关。
HIV 基因表达、NF-κB 激活基因表达以及
B 细胞中的免疫球蛋白类别转换与癌症有关。
模型系统 S. pombe 中对 Spt5 的初步研究知之甚少。
提供了强有力的证据表明 Spt5 是全基因组转录延伸正常水平所必需的,
RNA 聚合酶 II 需要 Spt5 才能延伸穿过屏障。
抑制一类新型反义转录物,该转录物在屏障处或附近启动并合成
具体目标 1 中提出的实验涉及三个基因的 5' 端。
相关领域,继续使用粟酒裂殖酵母作为模型系统。在目标 1.1 中,两种全基因组方法。
(MNase-seq 和 TSS-seq)将用于 (1) 测试 Spt5 是否控制染色质结构以及 (2)
绘制反义 RNA 的 5' 末端,作为定位反义启动子和屏障的方法
该结果将为Spt5在核小体中的作用提供新的、全面的表征。
目标 1.2 将重点关注具有三种可能功能的序列:
延伸障碍、反义启动子和刺激延伸的可能位点。
进行并测试以定义这些功能所需的序列,结果将提供新的见解。
Aim 1.3 深入研究了真核转录延伸的一个先前未研究的方面。
本身,重点关注损害伸长的新 spt5 突变的分离。
突变蛋白将揭示对 Spt5 蛋白功能的新认识。 具体目标 2 提出了实验。
目的 2.1 提出了两种方法:RNA-seq 和 RNA-seq。
NET-seq,用于表征 Spn1 耗尽细胞中转录的变化,以及 ChIP-nexus,一种高分辨率
ChIP-seq 方法,用于表征特定因素和组蛋白修饰后染色质的关联
Spn1 耗尽。目标 2.2 提出隔离不需要 Spn1 的突变,以了解
初步研究中分离出的 Spn1 突变的要求已确定了所需的因素。
这些研究将为 Spn1 在转录延伸中的功能提供新的见解。
这些研究将极大地促进对 Spt5 和 Spn1 的理解。
并增加对转录和共转录过程的理解。
如果保守的话,研究这些模型系统所学到的知识将与人类生物学直接相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRED M. WINSTON其他文献
FRED M. WINSTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRED M. WINSTON', 18)}}的其他基金
Analysis of conserved eukaryotic transcription elongation factors
保守的真核转录延伸因子分析
- 批准号:
10531245 - 财政年份:2021
- 资助金额:
$ 48.95万 - 项目类别:
Analysis of conserved eukaryotic transcription elongation factors
保守的真核转录延伸因子分析
- 批准号:
10321279 - 财政年份:2021
- 资助金额:
$ 48.95万 - 项目类别:
Analysis of the Essential Transcription Factors Spt5 and Spn1/Iws1
必需转录因子 Spt5 和 Spn1/Iws1 的分析
- 批准号:
9980444 - 财政年份:2017
- 资助金额:
$ 48.95万 - 项目类别:
Analysis of the Essential Transcription Factors Spt5 and Spn1/Iws1
必需转录因子 Spt5 和 Spn1/Iws1 的分析
- 批准号:
9555017 - 财政年份:2017
- 资助金额:
$ 48.95万 - 项目类别:
相似国自然基金
AP2-G反义非编码RNA调控恶性疟原虫配子生殖的作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
反义寡核苷酸诱导一种新型RNA编辑的研究
- 批准号:32271346
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
变异链球菌反义vicR RNA内源性转录调控机制干预胞外多糖代谢及致龋性的研究
- 批准号:82170948
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
反义增强子RNA/BRD4复合体促进前列腺癌对JQ1耐药机制的研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
长链非编码RNA BAALC-AS1的m6A 甲基化修饰在食管鳞状细胞癌中的作用及机制研究
- 批准号:81902835
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms and SMN-independent therapies for spinal muscular atrophy
脊髓性肌萎缩症的机制和不依赖 SMN 的疗法
- 批准号:
10435837 - 财政年份:2022
- 资助金额:
$ 48.95万 - 项目类别:
BIOLOGICS SUBJECT MATTER EXPERT (SME) CONSULTING SERVICES
生物制品主题专家 (SME) 咨询服务
- 批准号:
10788054 - 财政年份:2022
- 资助金额:
$ 48.95万 - 项目类别:
Molecular brush-conjugated antisense oligonucleotide as a pan-KRAS depletion agent
分子刷偶联反义寡核苷酸作为泛 KRAS 耗竭剂
- 批准号:
10544115 - 财政年份:2022
- 资助金额:
$ 48.95万 - 项目类别:
BIOLOGICS SUBJECT MATTER EXPERT (SME) CONSULTING SERVICES
生物制品主题专家 (SME) 咨询服务
- 批准号:
10829324 - 财政年份:2022
- 资助金额:
$ 48.95万 - 项目类别: